Login / Signup

Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.

Ahmed KamalRamy Mohamed GhazyDalia E SherifAliaa IsmailWalid Ismail Ellakany
Published in: BMC infectious diseases (2023)
The trial was registered on Clinicaltrials.gov NCT05035186. Date of registration is 2-09-2021.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • coronavirus disease
  • sars cov
  • clinical trial
  • combination therapy
  • respiratory syndrome coronavirus